Skip to content
2000
Volume 20, Issue 2
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

An emerging safe and efficient targeted method of treating many different types of cancer is radiopharmaceutical treatment (RPT). RPT uses medications that either bind more selectively to cancer cells or accumulate through physiological processes to deliver radiation either systemically or locally. Nearly all radionuclides employed in RPT generate imageable photons, allowing for noninvasive visualization of the therapeutic agent's biodistribution. RPT has demonstrated efficacy with little toxicity when compared to practically all other systemic cancer treatment approaches. The tremendous potential of this treatment is finally being acknowledged as a result of the FDA's recent approval of many RPT medicines. The fundamental characteristics, clinical advancement, and related difficulties of RPT are covered in this review.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/1573394719666230717103228
2024-03-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/1573394719666230717103228
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test